(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

4BASEBIO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

4BASEBIO

ST13

US500000088683659

Classe

1, 5, 9, 42, 45

Pedido

88683659

Registro

6128489

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

25

Atualização mais recente

19/08/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 42, 45

Data de depósito

07/11/2019

Data de registro

18/08/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

18/08/2020

Última transação

19/08/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

84

Localização do titular

CAMBRIDGESHIRE, GB

Examinador

RIRIE, VERNA

Unidade examinadora

L40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

4BASEBIO PLC
4BASEBIO UK SOCIETAS
4BASEBIO SE
4BASEBIO AG
4BASEBIO AG

Representantes

Andrew J. Avsec CROWELL & MORING LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 42Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicalbiochemicalbiological and biotechnological reagents and diagnostic preparations for laboratory research use in the fields of life sciencebiotechnology and genomics; diagnostic laboratory reagents and preparations for scientific use in the fields of life sciencebiotechnology and genomics

Classe 5

Chemical reagents for use in medical laboratories for medical diagnostic purposes; diagnostic preparations and reagents for use in medical laboratories for medical diagnostic purposes; biochemicalbiologicalbiotechnological reagents and diagnostic preparations for use in medical laboratories for medical diagnostic purposes

Classe 9

Scientific and laboratory apparatusinstruments and equipment for the measurement of the quantity of chemicalbiochemical and biological components in genomic and nucleic acids for scientific research and analysis; laboratory apparatusequipment and instruments for the analysis of the components of nucleic acids; kits comprised of laboratory apparatusdevicesinstruments and equipment for the measurement of the quantification of chemicalbiochemical and biological components of genomic and nucleic acids for scientific research purposes

Classe 42

Laboratory research services in the fields of life sciencebiotechnology and genomics; scientific research services in the fields of life sciencebiotechnology and genomics; biologicalbiotechnologicalchemical and biochemical scientific researchanalysis and product development services in the fields of life sciencebiotechnology and genomics; contract scientific research services in the fields of life sciencebiotechnology and genomics; nucleic acid research and development; nucleic acids and genomics research and development services for drugs and pharmaceutical product development and research; scientific research in the field of nucleic acids productionprocessing and purification; consultancy services relating to nucleic acids and genomics research; medical research services for nucleic acids for therapeutic or diagnostic use; medical research concerning the purification and production of nucleic acids for therapeutic or diagnostic use

Classe 45

Exploitation through licensing of intellectual property rights in the fields of life sciencebiotechnology and genomics; information and advice relating to intellectual property licensing in the fields of life sciencebiotechnology and genomics

Publicações

Histórico de despachos e eventos da marca no USPTO.

25 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

18/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

25/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

25/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

25/06/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/06/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

25/06/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/08/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/04/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

20/01/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

18/08/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/06/2020

PUBO

PUBLISHED FOR OPPOSITION

02/06/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/05/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

28/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/04/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/04/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/04/2020

ALIE

ASSIGNED TO LIE

26/03/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

19/03/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

28/02/2020

GNRT

NON-FINAL ACTION E-MAILED

28/02/2020

CNRT

NON-FINAL ACTION WRITTEN

28/02/2020

DOCK

ASSIGNED TO EXAMINER

11/02/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

14/11/2019

NWAP

NEW APPLICATION ENTERED

11/11/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace 4BASEBIO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.